SABCS 2022 | Key challenge associated with the management of HR+/HER2- breast cancer

Annelie Johansson, PhD, Karolinska Institutet, Stockholm, Sweden, talks on the significant challenge associated with the management of HR-negative, HER2- breast cancer of the long-term or late-risk development of distant metastatic disease, including procuring long-term follow-up data and understanding the mechanisms behind late recurrence. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.